Beth Sandy, MSN, CRNP

Beth Sandy, MSN, CRNP, discusses the application of 2 FDA approved drugs for patients with non–small cell lung cancer and an exon 20 insertion mutation.

Small cell lung cancer is very sensitive to chemotherapy, but immunotherapy offers another line of treatment for when chemotherapy stops working.

When it comes to immunotherapy-related adverse events, patients with lung cancer tend to have higher rates of pneumonitis than other cancer types, one nurse explains.